Profil
Mr. Dalen Meeter is a Chief Financial Officer at Aspen Neuroscience, Inc. Mr. Meeter was previously employed as a Chief Financial & Accounting Officer by Singular Genomics Systems, Inc. and a Senior Director-Finance by Illumina, Inc. He received his undergraduate degree from the University of California, Santa Barbara and an MBA from USC Marshall School of Business.
Aktiva positioner av Dalen Meeter
| Företag | Position | Start |
|---|---|---|
Aspen Neuroscience, Inc.
Aspen Neuroscience, Inc. BiotechnologyHealth Technology Operates as a clinical-stage regenerative medicine biotechnology company and develops autologous induced-pluripotent stem cell | Finansdirektör/CFO | 2025-03-10 |
Tidigare kända positioner av Dalen Meeter
| Företag | Position | Slut |
|---|---|---|
| SINGULAR GENOMICS SYSTEMS, INC. | Finansdirektör/CFO | 2025-02-21 |
| ILLUMINA, INC. | Finansdirektör/CFO | 2017-01-06 |
Dalen Meeters utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 5 |
|---|---|
Illumina, Inc.
Illumina, Inc. Medical SpecialtiesHealth Technology Operates as a biotechnology company that develops laboratory instruments | Health Technology |
University of California, Santa Barbara
University of California, Santa Barbara Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
USC Marshall School of Business
USC Marshall School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Singular Genomics Systems, Inc.
Singular Genomics Systems, Inc. Miscellaneous Commercial ServicesCommercial Services Develops scalable spatial multiomics technology for precision diagnostics and personalized medicine | Commercial Services |
Aspen Neuroscience, Inc.
Aspen Neuroscience, Inc. BiotechnologyHealth Technology Operates as a clinical-stage regenerative medicine biotechnology company and develops autologous induced-pluripotent stem cell | Health Technology |
















